NP
LLY icon

Ninepoint Partners’s Eli Lilly LLY Stock Holding History

Ninepoint Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Buy
2,810
+2,027
+259% +$2.07M 0.26% 48
2026
Q1 		$720K Buy
783
+178
+29% +$180K 0.05% 102
2025
Q4 		$650K Sell
605
-53
-8% -$50.7K 0.07% 91
2025
Q3 		$502K Buy
+658
New +$490K 0.07% 98
2025
Q2 		– Sell
-1,089
Closed -$899K – 97
2025
Q1 		$899K Sell
1,089
-90
-8% -$74.9K 0.15% 66
2024
Q4 		$910K Buy
1,179
+281
+31% +$233K 0.13% 71
2024
Q3 		$796K Buy
898
+789
+724% +$709K 0.09% 64
2024
Q2 		$98.7K Buy
+109
New +$87.2K 0.01% 101

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ninepoint Partners's LLY Position: Q2 2026 in Review

Ninepoint Partners increased its Eli Lilly (LLY) stake by 259% in Q2 2026, buying an estimated $2.07M and bringing the position to 2,810 shares worth $3.37M. The position accounts for 0.26% of the portfolio, ranked #48.

Ninepoint Partners first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ninepoint Partners held 2,810 shares of Eli Lilly worth $3.37M as of Q2 2026.
  • Ninepoint Partners bought 2,027 Eli Lilly shares in Q2 2026, an estimated $2.07M.
  • Eli Lilly made up 0.26% of Ninepoint Partners's portfolio in Q2 2026, its #48 holding.
  • Ninepoint Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ninepoint Partners's 13F filing for Q2 2026, filed 11 Aug 2026.